FluoGuide A/S (STO:FLUO)
Sweden · Delayed Price · Currency is SEK 32.50
+0.40 (1.25%)
Jul 24, 2026, 4:13 PM CET
FluoGuide Market Cap
FluoGuide has a market cap or net worth of 524.81 million as of July 24, 2026. Its market cap has decreased by -6.02% in one year.
Market Cap
524.81M
Enterprise Value
472.97M
Revenue
349.42K
Ranking
n/a
PE Ratio
n/a
Stock Price
32.50
ChartMarket Cap Chart
Since May 13, 2019, FluoGuide's market cap has increased from 40.02M to 524.81M, an increase of 1,211.30%. That is a compound annual growth rate of 42.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 524.81M | -6.41% |
| Dec 30, 2025 | 560.78M | 5.17% |
| Dec 30, 2024 | 533.23M | -28.57% |
| Dec 29, 2023 | 746.52M | 68.50% |
| Dec 30, 2022 | 443.04M | -54.38% |
| Dec 30, 2021 | 971.21M | 4.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medivir AB | 1.05B |
| SynAct Pharma AB | 984.46M |
| Infant Bacterial Therapeutics AB | 883.73M |
| AlzeCure Pharma AB | 877.03M |
| Xspray Pharma AB | 738.75M |
| Oncopeptides AB | 627.72M |
| Cantargia AB | 472.36M |
| Corline Biomedical AB | 458.64M |